mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.03 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |